"Moorabbin Hospital provides the following services: Monash Cancer Centre, orthopaedics, haemodialysis, ear, nose and throat, gynaecology, urology, diagnostic imaging, pastoral care, elective surgery and short-stay care."

During the past decade, Monash Medical Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monash Medical Centre" #1 sponsor was "Celgene" with 2 trials, followed by "Sirtex Medical" with 2 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "BeiGene" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monash Medical Centre" #1 collaborator was "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Australasian Kidney Trials Network" with 1 trials as a collaborator, "Australia & New Zealand Dialysis & Transplant Registry" with 1 trials as a collaborator, "Colorectal Surgical Society of Australasia (CSSA)" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Monash Medical Centre" are "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma of Rectum" (1 trials), "Advanced Cholangiocarcinoma" (1 trials), "Advanced Malignancies" (1 trials) and "Anaplastic Large-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Monash Medical Centre" in a lesser frequency.

Most popular intervention types in "Monash Medical Centre" are "Drug" (15 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "Placebo" (2 trials), "0.9% Saline" (1 trials), "Albumin-bound paclitaxel (ABI-007)" (1 trials) and "BGJ398" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monash Medical Centre" are 13 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Monash Medical Centre". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Monash Medical Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Monash Medical Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".